Colorectal Cancer Coverage from Every Angle
Advertisement
Advertisement

Michael J. Overman, MD, on Using the Vemurafenib Triple Regimen for Colon Cancer

Posted: Tuesday, January 22, 2019

How do you help patients who are given EGFR inhibitors to manage skin toxicities and the challenges of the regimen?



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.